Cancer Treatment Reviews
Volume 29, Issue 3 , Pages 227-229, June 2003

Adding androgen suppression to radiotherapy may improve disease-free survival over radiotherapy alone in locally advanced prostate cancer:☆☆☆★

Abstracted from: Bolla M, Collette L, Blank L et al. Long-term results with immediate androgen suppression and external irradiation in patients with locally advanced prostate cancer (an EORTC study): a phase III randomised trial. Lancet 2002; 360: 103–6.

Assistant Professor, Residency Program Director, Department of Radiation Oncology, University of Alabama-Birmingham, Birmingham, AL, USA

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

☆ Sources of funding: Not specified. Astra Zenica provided goserelin.

☆☆ Correspondence: M. Bolla, Radiotherapy Department, University Hospital, Grenoble, France. E-mail: MBolla@chu-grenoble.fr.

★ Abstract provided by Bazian Ltd., London.

PII: S0305-7372(03)00099-9

doi:10.1016/S0305-7372(03)00099-9

Cancer Treatment Reviews
Volume 29, Issue 3 , Pages 227-229, June 2003

Article Tools